Stay updated on Seagen Press Releases
Sign up to get notified when there's something new on the Seagen Press Releases page.

Latest updates to the Seagen Press Releases page
- Check7 days agoChange DetectedThe page now adds a Leadership section with the Chief Financial Officer transition release (06.18.2026) and a Supplier & B2B Resources link. It also removes the ELREXFIO press release from April 2026 and its related category labels.SummaryDifference2%

- Check14 days agoChange DetectedA new HYMPAVZI press release appears under Medicines/Prescription Medicines dated 06.08.2026, and older Finance/Corporate categories and the VYNDAMAX settlement release (04.28.2026) are removed from the page.SummaryDifference2%

- Check21 days agoChange DetectedJune 2026 press releases were added to the Newsroom, including updates on Berobenatide Phase 2b, a webcast invitation, and a BRAFTOVI regimen update. Older April 2026 releases were removed.SummaryDifference10%

- Check28 days agoChange DetectedFour May 2026 press releases were added to the Newsroom, covering TALZENNA Plus XTANDI results in metastatic prostate cancer, LORBRENA CROWN trial results in advanced NSCLC, a global collaboration with Innovent Biologics to accelerate oncology medicines, and an investor webcast invitation.SummaryDifference8%

- Check35 days agoChange DetectedAdds a new press release entry titled 'Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results' dated 05.20.2026 under the Research and Pipeline category, expanding the page's current press listings. Removes 'Pfizer logo' and 'Finance' items from navigation/branding areas.SummaryDifference3%

- Check43 days agoChange DetectedA new HYMPAVZI press release is added to the May 2026 list, and the TALZENNA Plus XTANDI entry is removed from March 2026. The page header branding now includes the Pfizer logo and a branded tagline.SummaryDifference3%

Stay in the know with updates to Seagen Press Releases
Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.